RxDoctor Payments Data

Jose Manuel, MD

Family Medicine · Sarasota, FLNPI 1558625863

Payments from drug & device makers

$3,487in general payments, 2019–2025

Across 187 payments — averaging $18.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$470
  • GSK$444
  • Bayer$403
  • Pfizer$352
  • Novartis$325
  • Exact Sciences$303
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,487100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,487 in reported general payments places this provider in the 80th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$76,676
Medicare patients
194
Services billed
1,077

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban110$124,999
JardianceEmpagliflozin110$108,313
OzempicSemaglutide86$99,426
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60$58,486
MounjaroTirzepatide36$37,382
LinzessLinaclotide38$25,776
EntrestoSacubitril/Valsartan19$21,180
XareltoRivaroxaban19$20,421
Tresiba Flextouch U-100Insulin Degludec24$19,290
FarxigaDapagliflozin Propanediol18$16,382
Tresiba Flextouch U-200Insulin Degludec20$15,205
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr22$14,840
TrulicityDulaglutide13$13,168
Repatha SureclickEvolocumab13$9,228
VascepaIcosapent Ethyl22$9,190

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$352$124,999110 claims
Boehringer IngelheimJardiance$43$108,313110 claims
Novo NordiskOzempic$239$99,42686 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$444$81,279100 claims
Lilly USA, LLCMounjaro, Trulicity$470$50,55049 claims
AbbVieLinzess$119$25,77638 claims
AstraZenecaFarxiga, Breztri Aerosphere$166$24,45331 claims
NovartisEntresto$325$21,18019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Sarasota

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →